Medical News: AAN: Broader Epilepsy Use Touted for Rufinamide - in Meeting Coverage, AAN from MedPage Today

Links shared publicly online about this topic.

  • 1,238
    total visits

Medical News: AAN: Broader Epilepsy Use Touted for Rufinamide - in Meeting Coverage, AAN from MedPage Today

medpagetoday.com

TORONTO -- Rufinamide (Banzel) was an effective treatment for refractory partial onset seizures in a phase III study, which could bring the drug to a much larger market, it was reported here.

View full resource at medpagetoday.com

Tags: Seizure, Epilepsy, Drug, News, Medical

  • Share

Most Recently Shared on April 15, 2010 at 6:37 pm By:

medical_tweets medical_tweets

AAN: Broader Epilepsy Use Touted for Rufinamide (CME/CE) TORONTO (MedPage Today) -- Rufinamide (Banzel) was an effectiv.. http://dld.bz/aurW

2 years ago...

Advertisement